GV

GV Management Company, LLC, established in 2009 as the venture capital arm of Alphabet Inc., specializes in investments across various stages, including seed, early, and late-stage funding. Based in Mountain View, California, with additional offices in Boston, New York, Seattle, Cambridge, and London, GV focuses on sectors such as life sciences, healthcare, artificial intelligence, robotics, transportation, cybersecurity, and agriculture. The firm has invested in over 300 companies, aiming to drive innovation and improve lives. GV seeks to make investments of up to $50 million, while offering early-stage startups funding of up to $250,000, typically taking minority stakes in these companies. Through its extensive network, GV provides startups with unique access to technology and talent, enhancing their potential for success.

Karim Faris

General Partner

Crystal Huang

Partner

Rick Klau

Partner

David Krane

Managing Partner

Daniel Lynch

Executive Venture Partner

David P. Schenkein

General Partner

KJ Sidberry

Principal

Krishna Yeshwant

General Partner

Sangeen Zeb

General Partner

Past deals in North America

Comanche Biopharma

Venture Round in 2023
Comanche Biopharma is a biopharmaceutical company that develops siRNA therapy for the treatment of preeclampsia.

AMP Robotics

Series C in 2023
AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Cerevance

Series B in 2023
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle the early onset of various neurological diseases.

Jetpack

Seed Round in 2023
Jetpack creates scalable cloud backend software for engineers to help them with coding and cloud services. The platform develops software that builds scalable web backends for the cloud and creates images and configurations directly from annotated python code.

Flatfile

Series B in 2022
Flatfile Inc. offers a platform designed to streamline the data onboarding process for businesses by allowing developers to validate, map, and import data from various web applications. Founded in 2018 and based in Denver, Colorado, the company's key products include Portal, an import button that integrates seamlessly into software applications through a JavaScript snippet, and Concierge, which provides secure workspaces for collaboration on data ingestion challenges. Flatfile's platform supports multiple file formats, including CSV, XLS, and TSV, and features a JavaScript configurator that enables users to define target models for data validation. This automation helps organizations manage and structure imported data effectively, reducing the time spent on data cleaning and allowing teams to focus on utilizing their data for decision-making.

Sardine

Series B in 2022
FinTech, RegTech, Fraud Operating System

Pretzel Therapeutics

Series A in 2022
Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

Omni

Series A in 2022
Omni is the only BI platform that combines the consistency of a shared data model with the freedom of SQL. Omni was founded in 2022 and was headquartered in California, United States.

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Vicinitas Therapeutics

Series A in 2022
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Merlin Labs

Series B in 2022
Merlin Labs is building an autonomous infrastructure for the sky above us, enabling goods, and eventually people, to fly without pilots.

Xilis

Series A in 2022
Xilis, Inc. develops next generation organoid technologies to guide precision therapy for cancer patients and improve drug discovery. It offers The XilisµO, a platform that enables rapid diagnostics, personalized drug screening, and scalable patient-derived models for high-throughput drug discovery. Xilis, Inc. was founded in 2019 and is based in Chapel Hill, North Carolina.

MemSQL

Series F in 2022
MemSQL, now known as SingleStore, provides a real-time data warehouse solution that enables businesses to manage and operationalize diverse data across various platforms. The company focuses on facilitating faster adaptation to changing business needs and accelerating digital innovation by offering a unified platform for data management. SingleStore's services are available through major cloud providers such as AWS, Azure, and GCP, as well as through customized deployments. This flexibility allows organizations to run SingleStore's capabilities in environments that best suit their operational requirements.

Areteia Therapeutics

Series A in 2022
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

FYTO

Series A in 2022
FYTO provides innovative solutions which improve the economic and environmental sustainability of agriculture for farmers around the world. FYTO is developing: NOVEL NUTRIENT-DENSE CROPS that have ultra-high yields and ultra-low resource requirements, STATE-OF-THE ART CULTIVATION AND HARVESTING SYSTEMS for exceptional quality and consistency, CLIMATE-FRIENDLY METHODOLOGIES for resiliency and long-term sustainability, and a range of GROUNDBREAKING AGRICULTURAL PRODUCTS such as animal feed and biofertilizer.

Modular

Seed Round in 2022
Modular is an AI software developer platform that unifies the development and deployment of AI for everyone. The product breakthroughs will be powered by production quality infrastructure that brings together compilers and runtimes, is designed for heterogeneous computing, edge to datacenter distribution, and is focused on usability. Unifying software and hardware with a "just works" approach will save developers enormous time and increase their velocity.

Sanas

Series A in 2022
Sanas is a technology company that specializes in real-time accent translation services, aimed at reducing language barriers and facilitating clearer communication. Its innovative software allows users to speak in various accents without any noticeable lag, enabling better understanding among speakers. The solution is designed to be user-friendly, operating locally on devices, which gives individuals complete control over their accent-matching preferences. By providing the option to adjust accents during conversations, Sanas enhances communication experiences and promotes inclusivity in interactions.

Courier

Series B in 2022
Courier provides an API designed for developers to enhance user notification delivery by intelligently routing messages across various existing channels, such as email and messaging platforms. The API takes into account factors like user online status and previous engagement levels to determine the most effective communication method. Over the years, Courier has evolved significantly, continuously adapting to technological advancements to better serve its customers while maintaining stability in its management and operational approach. The company emphasizes the importance of customer success, fostering long-term relationships with its largest clients and collaborating closely to prepare for future developments in the industry.

Ahana

Series A in 2022
Ahana was founded as the first company focused on bringing PrestoDB-based ad hoc analytics offerings to market and working to foster growth and evangelize the Presto community. While Presto is in large-scale production deployment at large internet companies like Facebook, Uber, and Twitter, Ahana’s mission is to simplify ad hoc analytics for organizations of all shapes and sizes. We are an “All Remote” company, from the start.

Sesame

Series B in 2022
Sesame, Inc., operating as SesameCare, is a New York-based company that provides a platform for booking medical appointments and consultations. Founded in 2018, the company aims to simplify healthcare by connecting patients directly with doctors, offering transparent pricing and clear descriptions of medical services. SesameCare primarily serves uninsured individuals or those who prefer to pay for their healthcare services upfront. By addressing the complexities and hidden costs often associated with traditional healthcare, Sesame seeks to make quality medical care more accessible and affordable for a broader range of patients.

Nava

Series B in 2022
Nava is a New York-based company that specializes in health insurance brokerage services aimed at delivering high-quality, affordable healthcare solutions to employers and their employees. The firm provides a range of healthcare tools, year-round employee advocacy, and continuous measurement to assess and recommend healthcare plans. By focusing on these aspects, Nava helps clients manage their employee benefits effectively while reducing overall plan costs. This approach allows businesses to offer the necessary benefits to their workforce, ensuring both accessibility and affordability in healthcare coverage.

Strella Biotechnology

Series A in 2022
Strella Biotechnology, Inc. designs and manufactures sensors based device that maximizes the freshness of fresh produce throughout the supply chain. The company provides an ethylene-detection device that determines ripeness by calculating the ethylene gas produced by fruit and maximizes freshness and reduces spoilage of fruit. Strella Biotechnology, Inc. was founded in 2018 and is based in Philadelphia, Pennsylvania.

FarmWise

Series B in 2022
FarmWise Labs, Inc. specializes in the development and manufacturing of robotic machinery aimed at improving agricultural practices. The company focuses on creating vegetable weeders that offer effective weeding and thinning solutions, while also monitoring the growth of herbicides. Founded in 2016 and located in San Francisco, California, FarmWise employs mechanical engineering to enhance farming efficiency and streamline operations, ultimately supporting increased food production. The company was previously known as DeepLook, Inc.

Gametime

Venture Round in 2022
Gametime United, Inc. develops a mobile application to book tickets. The company’s application enables users to buy and sell tickets for NBA, NHL, MLB, MLS, NCAA, and NFL teams. It offers its application for iOS and Android platforms through App Store and the Google Play Store. The company was founded in 2012 and is based in San Francisco, California.

Motive

Series F in 2022
Motive, formerly known as KeepTruckin, Inc., is a San Francisco-based company that specializes in fleet management software and electronic logbook applications for mobile devices. Founded in 2013, Motive offers a comprehensive fleet management system designed for dispatchers, drivers, fleet managers, and owner-operators. Its solutions enable dispatchers and fleet managers to audit driver logs, track locations, and relay load information to drivers. The application allows drivers to send and record their driving logs, conduct vehicle inspections, and communicate with back-office personnel to enhance hours-of-service compliance and safeguard their CSA scores. Motive's electronic logging device (ELD) is recognized as one of the most user-friendly and affordable systems available. Trusted by over 400,000 drivers and 13,000 fleets, Motive aims to improve the efficiency and profitability of the trucking industry through innovative technology. The company has received backing from prominent investors, including Google Ventures and Index Ventures.

Mirvie

Series B in 2022
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.

Graft

Pre Seed Round in 2022
Graft is a cloud-native platform that uses AI techniques to unlock the value of text, images, video, audio, and graphs. There is no requirement for machine learning skills, no need to hire a team, and no infrastructure to build or maintain.

Invetx

Series B in 2022
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, that specializes in developing protein-based therapeutics for animal health care. The company focuses on creating biopharmaceutical solutions that apply human biotechnology advancements to veterinary medicine. Invetx aims to build a premier innovation platform for veterinary therapeutics, collaborating with leading biotechnology firms, investors, and industry experts. Its team, which includes veterinary scientists and clinicians, is dedicated to discovering and developing a diverse portfolio of therapies and technologies. The company's vision is to enhance health outcomes for both pets and farm animals by leveraging biopharma technologies in the global animal health industry.

Aspen Neuroscience

Series B in 2022
Aspen Neuroscience, Inc. is a private biotechnology company based in San Diego, California, focused on developing innovative therapies for neurological conditions, particularly Parkinson's disease. Established in 2018, the company utilizes induced pluripotent stem cells to create patient-specific restorative cell therapies. Its product pipeline includes ANPD001, an autologous neuron replacement therapy designed for sporadic Parkinson's disease, and ANPD002, a gene-edited version aimed at familial forms of the disease. Aspen Neuroscience combines genomic approaches with stem cell biology to advance its mission of modifying the course of Parkinson's disease through these novel therapeutic strategies.

Veza

Venture Round in 2022
Cookie.AI is a stealth-mode startup based in the Silicon Valley / Bay Area. We are building SaaS based security products in a dynamic and fast moving world of cybersecurity with ideas rooted in the era of privacy for the cloud. We are well-funded and backed by top-tier VCs and CEOs as angel investors. The founders are serial entrepreneurs who have experience in the full 0-to-1 journey with a successful exit with an acquisition. We are looking for founding engineers (summer interns also welcome!) with strong interests in security / cloud-native systems / identity / SaaS.

Waltz Health

Series A in 2022
Waltz Health operates in the pharmaceutical supply chain, focusing on creating innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company develops consumer tools aimed at guiding decisions related to prescription care, with a particular emphasis on the needs of both payers and consumers. By utilizing AI-driven marketplaces, Waltz Health seeks to reduce costs and enhance the decision-making process for users. Their offerings provide better pricing information and resources that empower consumers while assisting payers in managing their pharmacy benefits more effectively.

Viz

Series D in 2022
Viz helps physicians to identify anomalies in brain scans through machine learning. The company leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat. It uses deep learning algorithms to identify a suspected large vessel occlusion, a particularly disabling type of stroke, in a CT scan and alerts the stroke team specialist within minutes. Viz has developed deep learning algorithms to analyze brain scans for large vessel occlusions (LVOs), a disabling type of stroke. The company also allows the stroke center’s clinicians to rapidly share images back and forth. Viz's mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment and improve access to care. Viz was founded in 2016 and is based in San Francisco, California, USA.

StackBlitz

Seed Round in 2022
StackBlitz is a developer of an integrated software used to offer comprehensive facilities to computer programmers for software development. Its software consists of a source code editor, build automation tools, and a debugger for creating sharing live projects that enable clients to get started with angular or react project without the need to deal with the installation of dependencies. The company also allows the developer to edit offline and tweak the application in real-time without page refresh and preserving the application state.

Rattle

Series A in 2022
Rattle is a technology company that offers a Salesforce integration solution aimed at enhancing the efficiency of sales and customer experience teams. By allowing users to access and manage Salesforce directly through Slack, Rattle addresses common challenges related to Salesforce adoption. This integration enables sales representatives to log calls, track essential metrics, and update opportunities seamlessly, facilitating real-time visibility into customer relationship management. The platform has proven effective for industry leaders, saving sales representatives an average of 30 minutes per day in pipeline management and reducing data hygiene issues by up to 50%. Rattle's solution ultimately allows marketing professionals to focus more on customer engagement rather than internal processes.

Obsidian Security

Series C in 2022
Obsidian Security, Inc. is a technology company based in Newport Beach, California, specializing in cybersecurity solutions tailored for hybrid-cloud environments. Founded in 2017 by former members of renowned companies in the security sector, Obsidian Security focuses on leveraging artificial intelligence to address cyber threats. Its platform provides comprehensive services, including threat detection, breach remediation, and security hardening specifically for software as a service (SaaS) applications. The company's offerings aim to deliver intelligent identity protection and seamless security, enabling enterprises to safeguard their interconnected systems without hindering productivity. Backed by notable investors, Obsidian Security positions itself at the forefront of the evolving cybersecurity landscape.

Brightline

Series C in 2022
Brightline is a technology-enabled behavioral health home for children and their families. Brightline delivers integrated care through innovative technology, virtual behavioral health services, and a collaborative care team focused on supporting children across developmental stages and their families.

Celsius Therapeutics

Series B in 2022
Celsius Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, that focuses on the development and research of innovative drugs. Established in 2017, the company utilizes single-cell genomic analysis and machine learning to gain insights into the cellular ecosystems of diseases. This approach allows Celsius Therapeutics to identify critical biomarkers that can enhance patient care and contribute to the creation of transformative medicines. The company's commitment to advancing the understanding of complex diseases positions it as a key player in the biotechnology sector.

Digits

Series C in 2022
Digits Financial, Inc. develops software to provide real-time view into business’ finance. The company’s software facilitates processes related to financial reports and transaction records to eliminate manual work. It visualizes, understands, and manages business and handles interactions with accountants, investors, and advisors. The company was founded in 2018 and is based in San Francisco, California.

LifeMine Therapeutics

Series C in 2022
LifeMine Therapeutics, Inc., a biotechnology company, engages in the genomic discovery of new drug modalities from eukaryotic microbes. It utilizes an integrated genomically-enabled drug discovery platform to discover and develop a pipeline of new drugs from fungi. The company was incorporated in 2016 and is based in Cambridge, Massachusetts with an additional office in New York, New York.

Spotlight Therapeutics

Series B in 2022
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.

Agolo

Series A in 2022
Agolo summarizes information faster and with broader coverage than any human. It also uses artificial intelligence to create summaries from your information in real-time. The company helps analysts act strategically instead of processing information. Agolo’s technology replicates the ingenuity of the human mind by analyzing content through the identification of various subjects and drawing connections between them. The company’s AI platform can analyze thousands of documents and produce a summary of the five key points, specific to the reader’s interests, in real-time. Agolo was founded in 2012 and is headquartered in New York, NY, USA.

DNAnexus

Series H in 2022
DNAnexus, Inc. specializes in cloud-based genome informatics and data management tools tailored for enterprises and organizations involved in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company provides a platform that facilitates the analysis of raw sequencing data, integrates genomic data with clinical information, and enhances collaboration among researchers. Key offerings include the MOSAIC Microbiome platform for microbiome research, DNAnexus Apollo for clinico-genomic data exploration, DNAnexus Titan for data analysis, and DNAnexus Portals, which create secure online workspaces for collaborative projects. Additionally, the Clinico-Genomic Data Solution aims to enhance disease-specific datasets through partnerships with healthcare providers, improving screening and treatment pathways for complex diseases. DNAnexus serves a diverse clientele, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.

dbt Labs

Series D in 2022
Fishtown Analytics Inc. develops and operates a software-as-a-service (SaaS) based open-source data engineering platform. The company offers data build tool (dbt), which enables data analysts and engineers to organize, cleanse, denormalize, filter, rename, and pre-aggregate data for analysis. It offers data modeling, data warehousing, KPI measurement, event tracking, data science, and training services and data analytics consulting services. Fishtown Analytics Inc. was founded in 2016 and is based in Philadelphia, Pennsylvania.

Redpanda Data

Series B in 2022
Redpanda is a queue for people who deal with massive data streams.

RightHand Robotics

Series C in 2022
RightHand Robotics, Inc. specializes in manufacturing robotic order-picking systems designed for various industrial applications, including e-commerce, food handling, and flexible manufacturing. The company offers innovative products such as the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that enhances the robots' ability to grasp items gently and make adjustments to avoid errors. Their technology allows robots to automatically grasp a wide range of items from bins and cases, eliminating the need for extensive data-entry or parameter-tuning, thereby making the systems cost-effective and adaptable to the evolving needs of businesses. Founded in 2015, RightHand Robotics is headquartered in Cambridge, Massachusetts, with a sales and business development office located in Frankfurt, Germany.

Helium

Series D in 2022
Helium Systems Inc. specializes in Internet of Things (IoT) solutions, focusing on the development of smart sensor devices for various industries. These sensors monitor critical environmental factors such as temperature, humidity, barometric pressure, motion, and light, aiding in facility management and quality control for medical products, energy efficiency, air quality, and refrigeration. The company offers a web and mobile dashboard that allows users to manage and access their sensor data easily. Additionally, Helium operates a peer-to-peer wireless network designed to enhance connectivity for low-power IoT devices. This network incentivizes individuals to act as network operators by rewarding them with cryptocurrency for verifying transactions and maintaining coverage through a unique algorithm called Proof-of-Coverage. Incorporated in 2013 and based in San Francisco, Helium continues to innovate in the IoT space, providing robust solutions for data transfer and network connectivity.

Overview

Series A in 2022
Overview.ai provides real time fault detection that uses cameras and AI to monitor manufacturing robots, shutting them down if something goes wrong. Its smart camera automatically learns normal machine routines to detect any deviations, crashes or anomalies. Its system catches misalignments, breakage, and out-of-sequence behavior before significant damage occurs to product or machine.

Homebound

Series C in 2022
Homebound Inc. is a technology-driven custom home builder based in Santa Rosa, California, founded in 2017. The company specializes in constructing residential homes and offers a comprehensive range of support services, including architecture, design, financing, and insurance consultancy. Originating in response to the 2017 Northern California wildfires, Homebound aims to simplify the homebuilding process by providing a transparent and streamlined experience for homeowners. It manages the entire building journey, assisting clients from insurance negotiation and architectural design to permitting and construction. By leveraging user-friendly technology and a network of qualified building professionals, Homebound addresses the complexities and uncertainties homeowners face, particularly in the aftermath of natural disasters, enabling them to rebuild their homes more efficiently.

Neo.tax

Series A in 2022
Neo.tax is a tax preparation and filing service based in Mountain View, California, that specializes in assisting early-stage startups. The company offers a tax automation platform that employs machine learning algorithms to streamline the collection and organization of data from various sources, including emails, documents, project management tools, and financial systems. This technology generates comprehensive reports that detail all activities, expenses, and methodologies used to claim tax credits. By enhancing accuracy and simplifying the review process, Neo.tax aims to ensure that businesses are audit-ready, thereby facilitating a more efficient and reliable tax filing experience.

Seismic Therapeutic

Series A in 2022
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its IMPACT™ platform, Seismic Therapeutic aims to tackle key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This comprehensive approach facilitates the creation of optimized therapies that can reach patients more quickly. The company is developing a pipeline of innovative biologics targeting adaptive immune system dysregulation, with the goal of treating autoimmune diseases.

Scandit

Series D in 2022
Scandit AG, established in 2009 and headquartered in Zurich, Switzerland, specializes in mobile computer vision and augmented reality solutions, focusing on barcode scanning software. Its offerings include the Scandit Keyboard Wedge, which enables enterprise-grade barcode scanning on mobile devices, and the Barcode Scanner SDK, which allows for barcode scanning integration in web applications. The MatrixScan technology enhances the speed of barcode and text recognition, making it valuable for industries such as retail, logistics, manufacturing, healthcare, and government. Scandit's solutions are designed to improve operational efficiency by enabling mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating patient and medication tracking in healthcare settings. The company serves a diverse clientele, including well-known organizations like 7-Eleven, Carrefour, and Toyota, among others, and has additional offices in San Francisco, Boston, London, and Warsaw.

Ventus Therapeutics

Series C in 2022
Ventus Therapeutics U.S., Inc. is a biopharmaceutical company based in Natick, Massachusetts, with an additional location in Montreal, Canada. Founded in 2019, it focuses on discovering and developing novel small-molecule medicines that target the innate immune system to address autoimmune diseases, inflammatory diseases, and cancer. The company employs a structural immunology platform that integrates protein engineering to elucidate molecular structures and mechanisms of action. This platform facilitates the development of precise binding and functional screening assays, as well as structure-based modeling. Ventus Therapeutics is advancing an emerging pipeline of drug programs aimed at key targets within the innate immune system, leveraging its proprietary capabilities in rational and structure-based drug design.

Lacework

Venture Round in 2022
Lacework, Inc. is a cloud security platform that specializes in automating security and compliance across various cloud environments, including AWS, Azure, GCP, and private clouds. The company's flagship solution, Polygraph, enhances cloud workload security by integrating with cloud providers' security measures to protect customer accounts, workloads, and data. It effectively identifies anomalies and offers actionable insights for incident remediation. Lacework's offerings include continuous compliance, workload security, container security, and support for applications and services in cloud environments, leveraging DevOps processes and automated tools. Established in 2014 and headquartered in Mountain View, California, Lacework aims to provide a comprehensive view of risks associated with cloud workloads and containers, facilitating a secure transition to cloud infrastructure.

Synapticure

Seed Round in 2022
Synapticure is a tele neurology startup that provides tailored care to ALS (Amyotrophic Lateral Sclerosis) patients and their families.

Censys

Series B in 2022
Censys, Inc. is a cybersecurity company specializing in internet scanning and asset identification solutions. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides an internet device search engine that allows users to discover and analyze devices connected to the Internet, including computers, servers, and smart devices. The platform is utilized for various applications such as attack surface management, monitoring remote workforces, and identifying potential threats. Censys is recognized for delivering real-time visibility and risk assessments, making it a valuable resource for researchers, corporations, and government entities. The company's data-driven security solutions are employed by notable organizations, including FireEye, Google, NATO, and the U.S. Department of Homeland Security, to enhance their cybersecurity measures and proactively address threats.

TenSixteen Bio

Series A in 2022
TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases. The company uses somatic mosaicism and clonal hematopoiesis (CHIP) to find and develop new treatments for age-related disorders. Foresite Labs co-founded TenSixteen Bio, which is based in San Francisco.

Agtonomy

Seed Round in 2022
Agtonomy is a hybrid autonomy and tele-assist platform for agriculture vehicles.

Verana Health

Series E in 2022
Innovation in healthcare is hindered by the time and cost of bringing new products to market. Verana Health is partnering with medical associations to build a regulatory-grade data platform for health care innovation that utilizes specialty clinical data sets. Verana Health’s platform enables physicians and industry to work together towards their shared goal of accelerating the availability of better treatments and cures for patients. Learn more at veranahealth.com.

Cockroach Labs

Series F in 2021
Cockroach Labs, Inc. specializes in the development of open-source database software, notably CockroachDB, a cloud-native, distributed SQL database designed for modern application development. Founded in 2015 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a robust solution that combines the functionality of SQL with the horizontal scalability typical of NoSQL systems. CockroachDB is engineered to support strongly-consistent ACID transactions and offers an SQL API for data management. Its architecture ensures minimal latency disruption and resilience against failures across various levels, including disk, machine, rack, and datacenter. Serving a diverse clientele from startups to Fortune 500 companies, Cockroach Labs enables organizations across multiple industries, including banking, retail, and media, to build applications that can scale efficiently and maintain operational continuity.

Dialpad

Series F in 2021
Dialpad, Inc. is a cloud-based communications platform that specializes in enterprise-level solutions for voice, video, messaging, and collaboration. Founded in 2011 and based in San Francisco, the company offers a suite of products, including Dialpad, Dialpad Sell, UberConference, and Dialpad Contact Center, all powered by VoiceAI technology. These tools provide features such as real-time transcription, automated note-taking, live sentiment analysis, and voice analytics, catering to the growing demand for effective remote communication. Dialpad's clients include notable organizations such as Motorola Solutions and Warby Parker. The company has formed strategic partnerships, including one with SoftBank Corp., and has attracted investments from various venture capital firms. Initially known as Switch Communications, Dialpad rebranded in 2016 to reflect its focus on modern business communication needs, enabling employees to collaborate securely from any device within a unified platform.

Wonder

Series A in 2021
Wonder is a gaming company focused on developing an all-in-one gaming platform specifically for Android mobile devices. The platform enables users to play, stream, and share games seamlessly across different devices, thereby enhancing the overall gaming experience. Additionally, Wonder is exploring VR-ready gaming hardware to further enrich its offerings. Currently, the company operates in stealth mode, indicating that it is in the early stages of development and not yet publicly available.

Universe

Series B in 2021
Universe is a mobile-based website builder established in 2014 and headquartered in Brooklyn, New York. The platform aims to empower users to create customized websites quickly and easily, catering to the needs of small business owners and individuals who prefer mobile solutions. By offering a unique approach that eliminates complicated templates, Universe utilizes customizable website filters that allow users to arrange photos, videos, and icons on a grid pattern through a simple drag-and-drop interface. This enables users to build mobile-optimized websites in just minutes using the company's iOS app, providing them with full control over their online presence.

Quartet Health

Corporate Round in 2021
Quartet Health, Inc. develops and operates a cloud based platform that allows communication and collaboration between medical providers with behavioral health providers for patient care. Its platform works with health plans and health systems to provide actionable population insights and reports on behavioral health conditions to improve patient outcomes, as well as provides tools for patient self-management. The company was founded in 2014 and is based in New York, New York.

Groundswell

Seed Round in 2021
Groundswell provides a SaaS platform for philanthropic giving, which enables companies to fund personal donor-advised funds for each employee. Employee users are also provided with tools such as tax-free investment opportunities, customized giving opportunities, frictionless donation options, and centralized impact reporting.

Upbound

Series B in 2021
Upbound, Inc. develops and offers a multi-cloud platform that enables organizations to treat multiple disparate cloud environments as one. The company's platform allows organizations to build scalable multi-cloud services. Its platform allows for automation, cost optimization, capacity overflow, failover, policy enforcement, and portability across cloud environments. The company was founded in 2017 and is based in Seattle, Washington.

Vercel

Series D in 2021
Vercel Inc. is a cloud platform that specializes in on-demand deployment, hosting, and sharing services for frontend applications. Founded in 2015 and based in Walnut, California, the company provides automated deployment solutions integrated with GitHub, Bitbucket, and GitLab, allowing projects to be deployed seamlessly from pull requests and merge requests. Vercel's platform is designed to enhance the development and deployment experience for frontend teams by hosting static websites and serverless functions that align with the Jamstack deployment model. This model ensures that web pages are pre-rendered and can be efficiently served by a content delivery network, delivering optimal performance for developers. Vercel was formerly known as ZEIT, Inc. before rebranding in April 2020.

mabl

Series C in 2021
Mabl Inc. offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. Founded in 2016 and based in Boston, Massachusetts, the company provides a scriptless testing solution as part of its software-as-a-service (SaaS) offerings. Mabl facilitates machine-driven regression testing and integrates seamlessly into the continuous integration and continuous delivery (CI/CD) development lifecycle. Its platform allows software development teams to create, execute, and maintain auto-healing tests efficiently, ensuring the rapid delivery of high-quality applications. Mabl serves a range of enterprise clients, including Johnson Controls, Liberty Mutual, Molina Healthcare, JetBlue, Dollar Shave Club, and Charles Schwab, who rely on its services for testing their critical applications.

Farmer Business Network

Series G in 2021
Farmer Business Network (FBN) is an independent agronomic information network designed to enhance the livelihoods of farmers by making data accessible and useful. Leveraging data science and machine learning, FBN offers its members unbiased insights about their fields, drawing on billions of data points collected from a vast network of farmers. The platform provides valuable resources such as product performance analytics, benchmarking, and predictive insights based on real-world agricultural data. By connecting farmers across the United States, FBN helps them achieve input savings, gain profitable insights, and secure better crop prices, ultimately fostering a collaborative environment that benefits the agricultural community.

Yellowbrick Data

Series C in 2021
Yellowbrick Data was founded in 2014 by experts in database and flash memory technologies to simplify data warehousing. They wanted to solve the challenges of high availability, running complex mixed workloads, support for ad-hoc SQL, computing correct answers on any schema, massive scalability and supporting large numbers of concurrent users. Yellowbrick Data empowers companies to make faster decisions with all of their data. Built for enterprises and the hybrid cloud, the Yellowbrick Data Warehouse deploys powerful analytics anywhere, with best-in-class economics.

Antiva Biosciences

Series D in 2021
Antiva Biosciences is a biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego. They are now Antiva Biosciences which is headquartered in South San Francisco.

Patina

Series A in 2021
We believe everyone should have the opportunity to live their best lives and age with dignity. That’s why we’re reinventing primary care with an approach designed to profoundly improve the healthcare and aging experience for older adults and their loved ones.

Modern Age

Series A in 2021
Modern Age is a health and wellness platform focused on improving the aging process for individuals. It offers health monitoring software that employs computer vision and machine learning to assess skin, hair, and bone health. The platform also integrates data collected from smart bands to create a comprehensive digital record of an individual's well-being. By analyzing this information, Modern Age provides personalized insights and treatment recommendations, empowering users to manage their health more effectively and lead healthier lives as they age.

RightHand Robotics

Venture Round in 2021
RightHand Robotics, Inc. specializes in manufacturing robotic order-picking systems designed for various industrial applications, including e-commerce, food handling, and flexible manufacturing. The company offers innovative products such as the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that enhances the robots' ability to grasp items gently and make adjustments to avoid errors. Their technology allows robots to automatically grasp a wide range of items from bins and cases, eliminating the need for extensive data-entry or parameter-tuning, thereby making the systems cost-effective and adaptable to the evolving needs of businesses. Founded in 2015, RightHand Robotics is headquartered in Cambridge, Massachusetts, with a sales and business development office located in Frankfurt, Germany.

Sprinter Health

Series A in 2021
Sprinter Health is an on-demand mobile health company that sends full-time nurses and phlebotomists (“Sprinters”) into the home.

Matter

Series A in 2021
Matter operates as a social reading app for articles, blogs, and newsletters. The company is based in the United States.

IonQ

Post in 2021
IonQ, Inc. specializes in the development of general-purpose quantum information computers, utilizing a unique trapped ion approach. The company's technology combines high physical performance, perfect qubit replication, and optical networkability, enabling the creation of scalable quantum computers that surpass the limitations of classical computing. These advancements leverage phenomena such as superposition and entanglement, which are critical at the atomic scale. Founded in 2015 and headquartered in College Park, Maryland, IonQ aims to support a wide range of applications across various industries with its powerful and versatile quantum computing solutions.

Agtonomy

Seed Round in 2021
Agtonomy is a hybrid autonomy and tele-assist platform for agriculture vehicles.

Ripple Foods

Series E in 2021
Ripple Foods specializes in producing high-quality, dairy-free milk alternatives that prioritize nutrition and taste. Their products are designed to be high in protein, offering eight times the protein found in almond milk while containing half the sugar of traditional dairy milk. Additionally, Ripple's beverages are rich in bioavailable calcium, providing 50% more than regular milk, and are a good source of potassium and omega-3 fatty acids. With a focus on delivering a creamy texture that enhances the drinking experience, Ripple aims to provide a satisfying alternative for those seeking non-dairy options without sacrificing flavor or nutritional value.

Ripple Foods

Series E in 2021
Ripple Foods specializes in producing high-quality, dairy-free milk alternatives that prioritize nutrition and taste. Their products are designed to be high in protein, offering eight times the protein found in almond milk while containing half the sugar of traditional dairy milk. Additionally, Ripple's beverages are rich in bioavailable calcium, providing 50% more than regular milk, and are a good source of potassium and omega-3 fatty acids. With a focus on delivering a creamy texture that enhances the drinking experience, Ripple aims to provide a satisfying alternative for those seeking non-dairy options without sacrificing flavor or nutritional value.

Dapper Labs

Series D in 2021
Dapper Labs Inc. develops blockchain-based cryptokitties video games. The company offers consumer blockchain collectible cats games for entertainment brands. Dapper Labs Inc. was incorporated in 2018 and is based in Vancouver, Canada.

Altana AI

Series A in 2021
Altana AI specializes in developing artificial intelligence software solutions focused on enhancing global trade. Founded in 2018 and based in New York, the company leverages comprehensive global economic data to provide visibility across borders and improve risk management for governments, enterprises, and financial institutions. Altana's offerings include AI-based data fusion and decision support tools, centered around the Altana Trade Knowledge Graph. This innovative platform delivers a real-time overview of transactions, ownership, movements, cyber activity, and associated risks within the global trade network. By facilitating better data-driven insights, Altana aims to make trade safer, more efficient, and more profitable for its clients, including regulators, businesses, financial service providers, and logistics companies.

StrongDM

Series B in 2021
strongDM manages and audits access to servers and databases. It provides a single platform to control access to any database for employees, vendors, and cloud-based tools. The company was awarded in the Strata+Hadoop World Audience Favorite in 2016. It was incorporated in 2015 and is headquartered in Burlingame, California.

ROME Therapeutics

Series B in 2021
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, ROME Therapeutics is pioneering the exploration of the repeatome, which consists of extensive regions of genetic material previously considered "junk DNA." The company has identified several drug targets and is actively advancing multiple discovery programs. To facilitate its research, ROME has assembled a team of experts across various disciplines, including oncology, immunology, virology, and machine learning, to harness this uncharted area of biology for therapeutic advancements.

MemSQL

Series F in 2021
MemSQL, now known as SingleStore, provides a real-time data warehouse solution that enables businesses to manage and operationalize diverse data across various platforms. The company focuses on facilitating faster adaptation to changing business needs and accelerating digital innovation by offering a unified platform for data management. SingleStore's services are available through major cloud providers such as AWS, Azure, and GCP, as well as through customized deployments. This flexibility allows organizations to run SingleStore's capabilities in environments that best suit their operational requirements.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Snorkel AI

Series C in 2021
Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform designed for building, managing, and monitoring AI applications. Central to its offerings is Snorkel Flow, a data-first platform that enables users to programmatically label and augment training data, manage and integrate data for AI purposes, and train and deploy various models. The platform also facilitates the extraction of entities and relationships from complex documents and ranks content based on relevance. This technology is beneficial across multiple sectors, including finance, government, telecommunications, insurance, healthcare, and e-commerce. Founded in 2016 and based in Palo Alto, California, Snorkel AI is committed to making AI practical through its innovative tools and solutions.

FullStory

Series D in 2021
FullStory, Inc. is a company that specializes in customer experience analytics, offering a platform that captures and analyzes various customer interaction data. The platform provides features such as pixel-perfect session playback, automatic insights, and funnel analytics, enabling organizations to optimize their online customer experiences. FullStory serves a diverse range of professionals, including product managers, designers, developers, and support agents, by delivering valuable insights into user behavior and engagement. Founded in 2014 and headquartered in Atlanta, Georgia, FullStory was previously known as Monetology, LLC until its name change in 2015. The company has also established a strategic partnership with Digital Yalo to enhance its offerings.

Ahana

Series A in 2021
Ahana was founded as the first company focused on bringing PrestoDB-based ad hoc analytics offerings to market and working to foster growth and evangelize the Presto community. While Presto is in large-scale production deployment at large internet companies like Facebook, Uber, and Twitter, Ahana’s mission is to simplify ad hoc analytics for organizations of all shapes and sizes. We are an “All Remote” company, from the start.

Neuralink

Series C in 2021
Neuralink Corp. is a neural technology company focused on developing brain-computer interfaces (BCIs) that facilitate direct communication between the human brain and computers. Founded in 2016 and headquartered in San Francisco, California, with an additional office in Burlingame, the company aims to create implants that can treat brain injuries and trauma. Neuralink's innovative approach includes a concept referred to as a "neural lace," which would be surgically integrated into the brain, enabling users to interact with computers without the limitations of traditional input methods like keyboards and mice. The company is also exploring the potential of brain interfaces to alleviate symptoms of serious and chronic medical conditions, striving to enhance cognitive capabilities and keep pace with advances in artificial intelligence.

Nym

Venture Round in 2021
Nym Health Inc. specializes in developing advanced medical coding technology aimed at enhancing revenue cycle processes within healthcare facilities. Its flagship product, Nym, offers a direct-to-billing autonomous coding solution that significantly reduces claims denials and operational costs while accelerating payment cycles and ensuring audit-readiness. The platform automatically identifies and captures relevant clinical information from patient charts, assigning codes only to fully understood cases; unhandled charts are sent back for human coding. Additionally, Nym provides a detailed audit-trail view that explains the rationale behind each coding decision, facilitating quick comprehension for validation, compliance, and appeals purposes. Founded in 2017 and headquartered in Boston, Massachusetts, the company also maintains a research and development center in Tel Aviv-Yafo, Israel.

Norby

Seed Round in 2021
Norby is an audience relationship toolkit built for creators and brands.

TMRW Life Sciences

Series C in 2021
TMRW Life Sciences is a developer of a cryo-storage platform intended to improve the success rates of assisted reproductive technology. The company's platform offers an in-clinic robotic storage system and a fully digital chain of custody from clinic to offsite longterm storage, continuous remote and local monitoring and electronically integrated processes characterized by digital health signals received from every oocyte and embryo daily, enabling clients to streamline embryology lab operations, eliminate manual steps and integrates digital quality control.

Instawork

Series C in 2021
Instawork is the fastest growing career marketplace for hospitality professionals. We've changed how traditional recruiting works for small businesses (e.g a sign on the window) by turning the process into an automated matching solution. Our vision is to create economic opportunity for local businesses and professionals, globally. We're rapidly expanding across the US. We're looking for great talent to help us grow and would love to hear from you! Go to www.instawork.com or send us a note at careers@instawork.com

Xilis

Series A in 2021
Xilis, Inc. develops next generation organoid technologies to guide precision therapy for cancer patients and improve drug discovery. It offers The XilisµO, a platform that enables rapid diagnostics, personalized drug screening, and scalable patient-derived models for high-throughput drug discovery. Xilis, Inc. was founded in 2019 and is based in Chapel Hill, North Carolina.

Physna

Series B in 2021
Physna LLC designs and develops geometric search engine software for computer-aided design, 3-Diemsional printing, and other manufacturing methods. Its search engine breaks down 3-D files into a codified structure; and allows users to compare and analyze 3D models for the purpose of quality control and automated inspection. The company serves design, manufacturing, cybersecurity, aerospace, automotive, defense, consumer goods, electronics, and energy industries. Physna LLC was founded in 2015 and is based in Cincinnati, Ohio.

Kindbody

Series C in 2021
Kindbody operates a health and tech company intended to offer fertility services and treatments for the modern woman. It offers a full range of services including intrauterine insemination, in-vitro fertilization, donor support, egg freezing, and embryo freezing, enabling women to improve their overall health and wellbeing.